Clinical Laserthermia Valuation
| CLS-B Stock | SEK 3.78 0.04 1.07% |
At this time, the firm appears to be fairly valued. Clinical Laserthermia shows a prevailing Real Value of kr3.72 per share. The current price of the firm is kr3.78. Our model approximates the value of Clinical Laserthermia from analyzing the firm fundamentals such as Operating Margin of (23.95) %, return on equity of -2.59, and Shares Outstanding of 134.52 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Clinical Laserthermia's price fluctuation is risky at this time. Calculation of the real value of Clinical Laserthermia is based on 3 months time horizon. Increasing Clinical Laserthermia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Clinical stock is determined by what a typical buyer is willing to pay for full or partial control of Clinical Laserthermia Systems. Since Clinical Laserthermia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clinical Stock. However, Clinical Laserthermia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.78 | Real 3.72 | Hype 3.78 | Naive 3.53 |
The intrinsic value of Clinical Laserthermia's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Clinical Laserthermia's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Clinical Laserthermia Systems helps investors to forecast how Clinical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clinical Laserthermia more accurately as focusing exclusively on Clinical Laserthermia's fundamentals will not take into account other important factors: Clinical Laserthermia Total Value Analysis
Clinical Laserthermia Systems is currently projected to have takeover price of 73.29 M with market capitalization of 104.76 M, debt of 100 K, and cash on hands of 13.5 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Clinical Laserthermia fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
73.29 M | 104.76 M | 100 K | 13.5 M |
Clinical Laserthermia Investor Information
The book value of the company was currently reported as 0.18. The company recorded a loss per share of 1.08. Clinical Laserthermia had not issued any dividends in recent years. The entity had 200:1 split on the 25th of April 2024. Based on the key measurements obtained from Clinical Laserthermia's financial statements, Clinical Laserthermia Systems is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Clinical Laserthermia Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Clinical Laserthermia has an asset utilization ratio of 3.36 percent. This implies that the Company is making kr0.0336 for each dollar of assets. An increasing asset utilization means that Clinical Laserthermia Systems is more efficient with each dollar of assets it utilizes for everyday operations.Clinical Laserthermia Ownership Allocation
Clinical Laserthermia holds a total of 134.52 Million outstanding shares. Clinical Laserthermia Systems shows 9.7 percent of its outstanding shares held by insiders and 2.27 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Clinical Laserthermia Profitability Analysis
The company reported the revenue of 2.25 M. Net Loss for the year was (63.62 M) with loss before overhead, payroll, taxes, and interest of (3.63 M).About Clinical Laserthermia Valuation
The stock valuation mechanism determines Clinical Laserthermia's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Clinical Laserthermia based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Clinical Laserthermia. We calculate exposure to Clinical Laserthermia's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Clinical Laserthermia's related companies.Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Clinical Laserthermia's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Clinical Laserthermia's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Clinical Laserthermia's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Clinical Laserthermia's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Clinical Laserthermia's revenue streams: Identify Clinical Laserthermia's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Clinical Laserthermia's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Clinical Laserthermia's growth potential: Evaluate Clinical Laserthermia's management, business model, and growth potential.
- Determine Clinical Laserthermia's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Clinical Laserthermia's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.